DHT-U DRI Healthcare Trust

9.332USD13.35 CAD · TSX+0.75%Mkt Cap: 511.98M USDP/E: 12.36

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeu…

Insiders, last 90 days8 buys
Institutional holders1 on file

Key Statistics

Company
Market Cap511.98M USD
Enterprise Value907.75M USD
Revenue (TTM)200.52M USD
Gross Profit203.79M USD
Net Income (TTM)-50.47M USD
Revenue/Share3.64 USD
Last Price9.332 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees32
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA23344H1091
Valuation
P/E (Trailing)12.36
P/E (Forward)13.76
PEG—
EV/EBITDA7.55
EV/Revenue4.53
P/S3.65
P/B1.55
EPS (TTM)1.08 USD
EPS (Forward)0.97 USD
52W Range
7.48083% of range9.717
52W High9.717 USD
52W Low7.480 USD
Profitability
Gross Margin100.00%
Oper. Margin33.71%
EBITDA Margin85.72%
Profit Margin-32.91%
ROE-11.51%
ROA-5.35%
ROIC—
ROCE—
Growth
Revenue Growth-3.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF109.95M USD
CapEx (TTM)87.99M USD
FCF Margin-159.94%
FCF Yield-62.64%
Net Debt566.16M USD
Net Debt/EBITDA3.29
Net Debt/FCF—
Balance Sheet
Debt/Equity0.86
Current Ratio1.64
Quick Ratio1.32
Book Value/Sh8.64 USD
Cash/Share0.75 USD
Dividends
Fwd Div Rate0.31 USD
Trail. Div Rate0.30 USD
Div. Yield3.32%
5Y Avg Yield3.55%
Payout Ratio39.81%
Ex-Div DateDec 31, 2026
Pay DateOct 20, 2026
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)20.97 USD
Upside (mean)+124.7%
Target Range20.97 USD – 20.97 USD
# Analysts1
Ownership
Shares Out.54.86M
Float—
Insiders0.24%
Institutions52.84%
Short Interest
Short Ratio17757.4d
Short % Out.0.78%
Shares Short426.18K
Short (prev mo.)485.81K
Technical
SMA 508.714 (+7.1%)
SMA 2008.579 (+8.8%)
Beta0.54
S&P 52W Chg12.00%
Avg Vol (30d)101
Avg Vol (10d)120
Technical Indicators
RSI (14)68.3
MACD0.3249
MACD Signal0.1670
MACD Hist.+0.1580
BB Upper9.912 USD
BB Middle8.630 USD
BB Lower7.347 USD
BB Width29.72%
ATR (14)0.0699 USD
Vol Ratio (20d)28.99x

About DRI Healthcare Trust (TSE: DHT-U)

›

DRI Healthcare Trust (TSE: DHT-U) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 32 employees.

The shares were at 13.35 CAD on 19 November 2026, up 29.2% over 52 weeks. Its 52-week range is 10.70 CAD to 13.90 CAD: the price is 4.0% below the high and 24.8% above the low.

At a market capitalisation of 732.40M CAD, it trades at 12.4 times trailing earnings and 13.8 times forward earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, a discount of 50% for DHT-U. It pays a dividend yielding 3.32% (it pays out 40% of its earnings), against a median of 1.90% among the dividend payers in that peer group.

DRI Healthcare Trust reports return on equity of -11.5%, an operating margin of 33.7% and revenue down 3.8% year over year.

Its debt exceeds its cash by 566.16M USD, a debt-to-equity ratio of 0.86. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. One analyst covers the stock, with an average rating of Buy; their mean price target of 30.00 CAD is 124.7% above the current price. The next earnings report is expected on 3 March 2027.